Cash Flow Statement
Growth Metrics

Anika Therapeutics (ANIK) Interest Expenses (2020)

Anika Therapeutics has reported Interest Expenses over the past 1 years, most recently at $900000.0 for Q4 2020.

  • Quarterly Interest Expenses changed N/A to $900000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at $900000.0 for FY2020, N/A changed from the prior year.
  • Interest Expenses was $900000.0 for Q4 2020 at Anika Therapeutics.
  • Over five years, Interest Expenses peaked at $900000.0 in Q4 2020 and troughed at $900000.0 in Q4 2020.